We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

131 hedge funds and large institutions have $423M invested in Immunogen Inc in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 37 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

179% more call options, than puts

Call options by funds: $11.2M | Put options by funds: $4.03M

35% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 37

7% less funds holding

Funds holding: 141131 (-10)

30% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 30

47% less capital invested

Capital invested by funds: $795M → $423M (-$372M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
131
Holders Change
-10
Holders Change %
-7.09%
% of All Funds
3.49%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
21
Increased
50
Reduced
37
Closed
30
Calls
$11.2M
Puts
$4.03M
Net Calls
+$7.2M
Net Calls Change
+$2.39M
Name Holding Trade Value Shares
Change
Change in
Stake
Primecap Management
1
Primecap Management
California
$74M +$1.91M +208,677 +2%
ClearBridge Investments
2
ClearBridge Investments
New York
$69.8M +$4.28M +468,517 +4%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$57.4M -$7.71M -843,600 -8%
Vanguard Group
4
Vanguard Group
Pennsylvania
$32.4M +$1.24M +135,054 +3%
BB
5
BB Biotech
Switzerland
$19.8M +$686K +75,000 +2%
BFA
6
BlackRock Fund Advisors
California
$19.4M +$2.37M +259,033 +9%
State Street
7
State Street
Massachusetts
$19.2M +$2.98M +326,266 +12%
BIT
8
BlackRock Institutional Trust
California
$14.8M +$193K +21,084 +0.9%
Millennium Management
9
Millennium Management
New York
$9.09M +$12.3M +1,342,935 +917%
Norges Bank
10
Norges Bank
Norway
$9.04M +$5.87M +641,591 +76%
PA
11
Pinnacle Associates
New York
$7.56M +$29.5K +3,230 +0.3%
Morgan Stanley
12
Morgan Stanley
New York
$6.09M +$23.3K +2,550 +0.3%
Wells Fargo
13
Wells Fargo
California
$5.93M +$870K +95,188 +11%
Northern Trust
14
Northern Trust
Illinois
$5.91M -$297K -32,460 -3%
BIM
15
Bogle Investment Management
Massachusetts
$4.71M +$7.06M +771,842 New
D.E. Shaw & Co
16
D.E. Shaw & Co
New York
$3.81M +$5.72M +625,169 New
Deutsche Bank
17
Deutsche Bank
Germany
$3.3M +$1.27M +138,448 +34%
MAA
18
Managed Account Advisors
New Jersey
$3.27M +$457K +49,941 +10%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$3.25M +$496K +54,265 +11%
CS
20
Candriam SCA
Luxembourg
$2.96M +$4.44M +485,000 New
Bank of New York Mellon
21
Bank of New York Mellon
New York
$2.89M +$205K +22,393 +5%
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$2.79M +$3.4M +371,500 +428%
RJA
23
Raymond James & Associates
Florida
$2.52M +$1.14M +124,745 +43%
GIM
24
Granahan Investment Management
Massachusetts
$2.52M -$974K -106,532 -20%
NI
25
Numeric Investors
Massachusetts
$1.87M +$2.7M +295,189 +2,684%

IMGN Hedge Fund Activity: Q4 2014 in Review

131 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2014, worth a combined $423M — down 47% from $795M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of IMGN and 21 opened new positions — a net loss of 9 holders — while 37 trimmed existing stakes and 50 added.

The largest buyer was Millennium Management, adding an estimated $12.3M. The largest seller was First Trust Advisors, exiting entirely with an estimated $61.5M sold.

  • 131 institutional investors held Immunogen Inc (IMGN) as of Q4 2014, down from 141 in Q3 2014.
  • Funds reported $423M of Immunogen Inc stock for Q4 2014, down 47% quarter-over-quarter.
  • 21 funds opened new Immunogen Inc positions in Q4 2014 and 30 closed out, a net change of -9 holders.
  • The largest Immunogen Inc buyer in Q4 2014 was Millennium Management, an estimated $12.3M added.
  • The largest Immunogen Inc seller in Q4 2014 was First Trust Advisors, an estimated $61.5M sold.

Based on aggregated 13F filings for Q4 2014.